Atlas Trials

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Clinical trial NCT01058707 · COMPLETED

Trial details

NCT number
NCT01058707
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Malignancies
Start date
2010-01-04
Primary completion
2019-02-07
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.